What is the main business of Implai?

The main business activity of Implai focuses on manufacture of medical and dental instruments and supplies.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 10, 2011.

Where is the headquarters located?

The headquarters is located at: ul. Hutnicza 15B, 81-061 Gdynia.

Who is on the management board?

The management board includes Norbert Wilandt (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 126,000 (approx. $34,036).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

In 2025, the company generated total revenue of USD 661,747, representing an increase of 204.5% compared to 2024.

Is the company profitable?

Yes, the company recorded a net profit of USD 42,068 in 2025, meaning the company decreased its profit by 25.8%.

What is the largest operating cost?

The largest operating cost category falls under other operating costs. This category amounted to USD 282,670 in 2025, representing 50% of all operating expenses.

Implaisp. z o.o.

Manufacture of medical and dental instruments and supplies

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2011-03-10

Share capital

126 000,00 PLN

Activity description

Implai is a leading medical device company that develops advanced medical devices focused on joint health, including solutions centered around hyaluronic acid and platelet-rich plasma for joint regeneration. The company aims to empower healthcare professionals by providing effective treatments that alleviate discomfort and improve patients' quality of life.

Registered address

ul. Hutnicza 15B, 81-061 Gdynia, Poland

Website

implai.com

Phone

Social media

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 661.75kMedianUSD 244.19kAverageUSD 73.97m

Net profit

This companyUSD 42.07kMedianUSD 8.66kAverageUSD 3.21m

Operating costs

This companyUSD 567.84kMedianUSD 263.70kAverageUSD 67.37m

Assets

This companyUSD 250.52kMedianUSD 231.06kAverageUSD 47.07m

Industry

Bank accounts

Registered as a VAT taxpayer on 2013-10-21. Active

Bank Pekao SA
08 1240 1239 1787 0011 3010 5580
Bank Pekao SA
17 1240 5354 1978 0011 3818 1380
Bank Pekao SA
98 1240 5354 1111 0010 9600 7320

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

4 public aid cases recorded, with a total value of $8,559.

Grant date	Purpose	Gross amount	Granting body
Sep 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	——	Prezes Zakładu Ubezpieczeń Społecznych
Jun 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	——	Prezes Zakładu Ubezpieczeń Społecznych
Apr 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	——	Polski Fundusz Rozwoju S.A.

Tenders

No recorded participation in tenders.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Zuzanna Maria Wolniak — Management Board Member

Norbert Wilandt — President of the Management Board

Manner of representation

In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner
Wilandt Brothers S.A.

Beneficial owners

Person	Rights
Artur Maksymilian Wilandt (42)	1) fundator, 2) członek zarządu oraz 3) beneficjent artur wilandt fundacja rodzinna, która posiada 9 645 599 akcji (33,33% wszystkich akcji) w spółce wilandt brothers s.a. (krs: 0000912428), która posiada 100% udziałów w zgłaszanej spółce
Konrad Waldemar Wilandt (41)	1) fundator, 2) członek zarządu oraz 3) beneficjent konrad wilandt fundacja rodzinna, która posiada 9 645 599 akcji (33,33% wszystkich akcji) w spółce wilandt brothers s.a. (krs: 0000912428), która posiada 100% udziałów w zgłaszanej spółce
Norbert Wilandt (39)	1) fundator, 2) członek zarządu oraz 3) beneficjent norbert wilandt fundacja rodzinna, która posiada 9 645 599 akcji (33,33% wszystkich akcji) w spółce wilandt brothers s.a. (krs: 0000912428), która posiada 100% udziałów w zgłaszanej spółce

Competitors

Name	Revenue	Website
WS Tech Lorenssp. j.	$2,722,397.69	wstech.eu
Si-Curasp. z o.o.	$1,631,852.12	si-cura.pl
Kinesissp. z o.o.	$1,558,948.10	kinesis.com.pl
Salon Ortopedyczny Or-Techsp. z o.o.	$453,978.03	or-tech.pl
EndolinkS.A.	$378,334.26	endolink.pl
Platinumsp. z o.o.	$313,097.87	platinum-klinika.pl
Pinklabsp. z o.o.	$221,273.55	pinklab.pl
ChitomedP.S.A.	$206,587.41	chitomed.com
Your Labsp. z o.o.	$198,230.62	yourlab.pl
Medical InventiS.A.	$179,747.04	medicalinventi.pl

Change history

Date	Event
2023-03-30	Address change (Hryniewickiego 6b/135, 81-340, Gdynia → Ul. Hutnicza 15b, 81-061, Gdynia)
2022-03-30	Name change ("sumpto" → Implai)
2022-03-30	PKD change (Removed: 61.10.Z, 61.20.Z, 62.02.Z, 62.03.Z, 62.09.Z, 63.11.Z, 63.99.Z, 73.12.C, 96.09.Z; Added: 32.50.Z, 46.45.Z, 47.19.Z, 47.75.Z, 47.78.Z, 47.91.Z, 47.99.Z, 64.20.Z, 70.10.Z, 70.22.Z)
2016-09-13	Share capital change (120,000.00 PLN → 126,000.00 PLN)
2016-09-13	PKD change (Removed: 64.19.Z, 64.20.Z, 64.91.Z, 64.92.Z, 64.99.Z, 66.19.Z, 66.22.Z, 68.31.Z, 69.20.Z, 85.59.B; Added: 61.10.Z, 61.20.Z, 62.02.Z, 62.03.Z, 62.09.Z, 63.11.Z, 63.99.Z, 73.12.C, 96.09.Z)

FAQ

Last updated: 2026-08-25